Mechanism may be trumped by safety and efficacy, but as it also sets expectations for utility and influences clinical implementation, it is worth evaluating how well the notion of WDR5 inhibitors as an epigenetic anti-cancer therapy holds up when viewed a decade from its inception. Here, WDR5 is linked to cancer.